COVID-19: Rapid Antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testing

Tim Peto, UK COVID-19 Lateral Flow Oversight Team
doi: https://doi.org/10.1101/2021.01.13.21249563

Article usage

Article usage: January 2021 to May 2025

AbstractFullPdf
Jan 20212460993527
Feb 202122762361946
Mar 202113985981375
Apr 20211178516909
May 2021794484644
Jun 2021561507551
Jul 2021494706295
Aug 2021390563246
Sep 20211894284621
Oct 20211063110328
Nov 2021565151341
Dec 2021790176489
Jan 2022658189281
Feb 2022397254215
Mar 2022269147129
Apr 20226695480
May 20221394591
Jun 20221201760
Jul 20221142365
Aug 20221011249
Sep 2022962153
Oct 2022115940
Nov 20221041637
Dec 20227921104
Jan 2023741039
Feb 202355922
Mar 202375716
Apr 2023641119
May 202332319
Jun 20235189
Jul 202336515
Aug 2023441437
Sep 2023411727
Oct 2023521633
Nov 2023513611
Dec 2023411426
Jan 202434943
Feb 20244626177
Mar 2024543541
Apr 2024443623
May 2024352532
Jun 2024443651
Jul 2024393225
Aug 2024434040
Sep 2024262655
Oct 2024612632
Nov 202455827
Dec 2024371533
Jan 2025191922
Feb 2025326818
Mar 2025657524
Apr 2025605029
May 2025223412
Back to top
Posted January 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email
COVID-19: Rapid Antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation for mass-testing
Tim Peto, UK COVID-19 Lateral Flow Oversight Team
medRxiv 2021.01.13.21249563; doi: https://doi.org/10.1101/2021.01.13.21249563
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area